Logo image of SGD

SAFE & GREEN DEVELOPMENT COR (SGD) Stock Fundamental Analysis

NASDAQ:SGD - Nasdaq - US78637J2042 - Common Stock - Currency: USD

1.14  -0.03 (-2.56%)

Fundamental Rating

0

Taking everything into account, SGD scores 0 out of 10 in our fundamental rating. SGD was compared to 64 industry peers in the Real Estate Management & Development industry. SGD may be in some trouble as it scores bad on both profitability and health. SGD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SGD has reported negative net income.
SGD had a negative operating cash flow in the past year.
SGD Yearly Net Income VS EBIT VS OCF VS FCFSGD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 2M -2M -4M

1.2 Ratios

SGD's Return On Assets of -68.75% is on the low side compared to the rest of the industry. SGD is outperformed by 89.06% of its industry peers.
SGD has a Return On Equity of -1427.47%. This is amonst the worse of the industry: SGD underperforms 84.38% of its industry peers.
Industry RankSector Rank
ROA -68.75%
ROE -1427.47%
ROIC N/A
ROA(3y)-25.5%
ROA(5y)N/A
ROE(3y)-122.26%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SGD Yearly ROA, ROE, ROICSGD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 -50 -100 -150 -200

1.3 Margins

SGD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SGD Yearly Profit, Operating, Gross MarginsSGD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

0

2. Health

2.1 Basic Checks

SGD has less shares outstanding than it did 1 year ago.
The debt/assets ratio for SGD is higher compared to a year ago.
SGD Yearly Shares OutstandingSGD Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M 8M
SGD Yearly Total Debt VS Total AssetsSGD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2M 4M 6M 8M

2.2 Solvency

Based on the Altman-Z score of -3.83, we must say that SGD is in the distress zone and has some risk of bankruptcy.
SGD's Altman-Z score of -3.83 is on the low side compared to the rest of the industry. SGD is outperformed by 84.38% of its industry peers.
A Debt/Equity ratio of 14.52 is on the high side and indicates that SGD has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 14.52, SGD is doing worse than 85.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 14.52
Debt/FCF N/A
Altman-Z -3.83
ROIC/WACCN/A
WACCN/A
SGD Yearly LT Debt VS Equity VS FCFSGD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 2M -2M -4M

2.3 Liquidity

SGD has a Current Ratio of 0.08. This is a bad value and indicates that SGD is not financially healthy enough and could expect problems in meeting its short term obligations.
SGD has a worse Current ratio (0.08) than 92.19% of its industry peers.
SGD has a Quick Ratio of 0.08. This is a bad value and indicates that SGD is not financially healthy enough and could expect problems in meeting its short term obligations.
SGD has a Quick ratio of 0.08. This is amonst the worse of the industry: SGD underperforms 92.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
SGD Yearly Current Assets VS Current LiabilitesSGD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for SGD have decreased strongly by -2429.22% in the last year.
EPS 1Y (TTM)-2429.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-361.76%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SGD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SGD Price Earnings VS Forward Price EarningsSGD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SGD Per share dataSGD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SGD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SAFE & GREEN DEVELOPMENT COR

NASDAQ:SGD (4/22/2025, 8:00:01 PM)

1.14

-0.03 (-2.56%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.41%
Inst Owner Change0%
Ins Owners10.1%
Ins Owner Change0%
Market Cap2.29M
AnalystsN/A
Price TargetN/A
Short Float %12.05%
Short Ratio0.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.23
P/FCF N/A
P/OCF N/A
P/B 3.65
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-21.15
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.87
FCFYN/A
OCF(TTM)-0.77
OCFYN/A
SpS0.09
BVpS0.31
TBVpS-0.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -68.75%
ROE -1427.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-25.5%
ROA(5y)N/A
ROE(3y)-122.26%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 14.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 11089.5%
Cap/Sales 121.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z -3.83
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2429.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-361.76%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-129.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y38.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.07%
OCF growth 3YN/A
OCF growth 5YN/A